ExoCoBio Inc. announced that it has received $9.3 million in its Series C and Pre-IPO funding on August 25, 2020. The transaction included participation from existing investors K2 Investment Partners LLC, SBI Investment Korea Co., Ltd. (KOSDAQ:A019550), Dt&Investment Co.,Ltd., and new investors KNOTUS Co.,Ltd (KOSDAQ:A278650), ReeHu Investment, G.N.TECH Venture Capital Co., Ltd., and Focus Asset Management Co., Ltd. The company has raised $56.3 million in funding till date.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,610 KRW | +1.16% | -3.87% | -15.53% |
May. 20 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
May. 20 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.53% | 161M | |
+15.30% | 3.43B | |
+2.34% | 2.27B | |
-19.52% | 2.03B | |
-20.72% | 1.63B | |
+31.45% | 1.16B | |
+21.58% | 714M | |
-9.39% | 703M | |
-21.63% | 500M | |
-1.29% | 279M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- ExoCoBio Inc. announced that it has received $9.3 million in funding from a group of investors